Stocks
Korro Bio, Inc.KRRO
NASDAQHealthcareBiotechnology$8.91
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing a novel class of small-molecule therapeutics targeting RNA-modifying enzymes implicated in cancer and other diseases. Its lead program focuses on a specific enzyme target, with early-phase trials underway. Investors track the company for its potential to address previously undruggable targets in oncology.
52W Range: $5.20-$48.70
Congressional Interest in Korro Bio, Inc. (KRRO)
No congressional trades have been disclosed for Korro Bio, Inc. (KRRO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading KRRO?
No congressional trades found for this stock.